CN Patent
CN105324111B — 含多奈哌齐游离碱的薄膜制剂及其制备方法
Assigned to CTC BIO Inc · Expires 2019-06-28 · 7y expired
What this patent protects
本发明提供一种用于制备含有无味的多奈哌齐游离碱的薄膜的方法,所述薄膜具有适宜的尺寸和厚度,具有用于在操控时提供稳定性而不至于撕裂的灵活性,以及具有均匀分散的多奈哌齐游离碱。此外,本发明提供通过所述方法制得的含多奈哌齐游离碱的薄膜。
USPTO Abstract
本发明提供一种用于制备含有无味的多奈哌齐游离碱的薄膜的方法,所述薄膜具有适宜的尺寸和厚度,具有用于在操控时提供稳定性而不至于撕裂的灵活性,以及具有均匀分散的多奈哌齐游离碱。此外,本发明提供通过所述方法制得的含多奈哌齐游离碱的薄膜。
Drugs covered by this patent
- Zofran (ondansetron) · GSK (originally Glaxo)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.